Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aeovian Pharmaceuticals, Inc.

Clinical trials sponsored by Aeovian Pharmaceuticals, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New daily pill aims to tame stubborn seizures in tuberous sclerosis Results expected Sep 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

New daily pill aims to tame stubborn seizures in tuberous sclerosis

Disease control Not yet recruiting

This study tests an oral drug, AV078, in people aged 12 and older with tuberous sclerosis complex (TSC) whose seizures are not controlled by standard medications. Participants are randomly assigned to receive AV078 or a placebo for 12 weeks. The goal is to see if AV078 safely red…

Phase 2 • Sponsor: Aeovian Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jul 04, 2026 00:00 UTC